Most of the natural products isolated at present are heterocyclic compounds, so heterocyclic compounds occupy an important position in the research of organic chemistry. A compound: 1762-34-1, is researched, SMILESS is CC1=CN=C(C=C1)C1=NC=C(C)C=C1, Molecular C12H12N2Journal, Article, Chemistry – A European Journal called New Organometallic Ruthenium(II) Compounds Synergistically Show Cytotoxic, Antimetastatic and Antiangiogenic Activities for the Treatment of Metastatic Cancer, Author is Wang, Yuchen; Jin, Jiahui; Shu, Liwei; Li, Tongyu; Lu, Siming; Subarkhan, Mohamed Kasim Mohamed; Chen, Chao; Wang, Hangxiang, the main research direction is cyclometalated ruthenium complex human antitumor cytotoxicity antimetastatic antiangiogenic activity; metastatic cancer cyclometalated ruthenium human ovary lung liver skin; crystal structure mol cyclometalated ruthenium complex preparation; antiangiogenesis; antimetastasis; cancer chemotherapy; cytotoxicity; ruthenium(II) complexes.Computed Properties of C12H12N2.
In this study, we newly designed and synthesized a small library of ten structurally related C,N-cyclometalated ruthenium(II) complexes containing various pyridine-functionalized NHC ligand and chelating bipyridyl ligands (e.g., 2,2′-bipyridine, 5,5′-dimethyl-2,2′-bipyridine, and 1,10-phenanthroline (phen)). The complexes were well characterized by NMR, electrospray ionization-mass spectrometry, and single-crystal X-ray structure analyses. Among the new ruthenium(II) derivatives, we identified that the complex Ru8 bearing bulky moieties (i.e., phen and pentamethyl benzene) had the most potent cytotoxicity against all tested cancer cell lines, generating dose- and cell line-dependent IC50 values at the range of 3.3-15.0μM. More significantly, Ru8 not only efficiently inhibited the metastasis process against invasion and migration of tumor cells but also exhibited potent antivascular effects by suppressing HUVEC cells migration and tube formation in vitro and blocking vessel generation in vivo (chicken chorioallantoic membrane model). In a metastatic A2780 tumor xenograft-bearing mouse model, administration of Ru8 outperformed antimetastatic agent NAMI-A and clin. approved cisplatin in terms of antitumor efficacy and inhibition of metastases to other organs. Overall, these data provided compelling evidence that the new cyclometalated ruthenium complex Ru8 is an attractive agent because of synergistically suppressing bulky tumors and metastasized tumor nudes. Therefore, the complex Ru8 deserves further investigations.
This literature about this compound(1762-34-1)Computed Properties of C12H12N2has given us a lot of inspiration, and I hope that the research on this compound(5,5′-Dimethyl-2,2′-bipyridine) can be further advanced. Maybe we can get more compounds in a similar way.